Balance Sheet for Corcept Therapeutics Incorporated (CORT)

$ 22.99   0.16 (+0.70%) Volume: 461.45k 1:00 PM EST Nov 27, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 31,269 41,625 31,062 51,536 40,435
Restrictable Cash - - - - -
Marketable Securities 244,693 165,135 57,682 - -
Accounts Receivable 19,928 17,588 15,300 9,860 6,221
Loans Receivable - - - - -
Other Receivables - - 12,896 - -
Receivables 19,928 17,588 28,196 9,860 6,221
Inventories, Raw Materials 9,450 4,195 4,287 1,848 2,141
Inventories, Work in Progress 25,240 5,624 64 1,414 3
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 15,539 6,423 4,025 1,902 2,338
Inventories, Other 5,424 4,732 4,576 2,329 1,682
Inventories, Adjustments & Allowances (34,625) (11,510) (3,800) (2,835) (2,800)
Inventories 5,424 4,732 4,576 2,329 1,682
Prepaid Expenses 6,044 7,740 2,669 1,964 642
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 307,358 236,820 124,185 65,689 48,980
Land and Improvements - - - - -
Buildings and Improvement 533 35 14 6 -
Machinery, Furniture and Equipment 1,845 1,245 893 651 463
Construction in Progress - - - - -
Fixed Assets, Other 3,446 - - - -
Fixed Assets, Total 5,824 1,280 907 657 463
Gross Fixed Assets 5,824 1,280 907 657 463
Accumulated Depreciation (1,328) (625) (389) (452) (365)
Net Fixed Assets 4,496 655 518 205 98
Intangibles - - - - -
Cost in Excess - - - - -
Non-Current Deferred Income Taxes 45,677 62,659 76,703 - -
Other Non-Current Assets 15,429 11,560 3,850 2,859 2,824
Total Non-Current Assets 104,954 74,874 96,352 3,064 2,922
Total Assets 412,312 311,694 220,537 68,753 51,902
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 7,537 8,266 8,579 2,290 1,325
Short Term Debt 1,558 - 14,680 14,664 14,965
Notes Payable - - - - -
Accrued Expenses 16,943 17,886 12,350 5,718 3,325
Accrued Liabilities 16,943 17,886 12,350 5,718 3,325
Deferred Revenues - - - - 158
Current Deferred Income Taxes 16,877 14,067 (76,703) - -
Other Current Liabilities 12,803 9,421 (6,040) 4,702 1,103
Total Current Liabilities 38,841 35,573 29,569 27,374 20,876
Long Term Debt N/A N/A N/A - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities 386 239 - - 12,528
Minority Interest - - - - -
Capital Lease Obligations 1,903 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 2,289 239 - - 12,528
Total Liabilities 41,130 35,812 29,569 27,374 33,404
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 371,182 275,882 190,968 41,379 18,498
Common Par 120 117 115 113 110
Additional Paid in Capital 457,060 417,228 384,074 363,534 348,796
Cumulative Translation Adjustments - - - - -
Retained Earnings (23,555) (117,736) (193,146) (322,268) (330,408)
Treasury Stock 62,704 23,657 - - -
Other Equity Adjustments 261 (70) (75) - -
Total Capitalization 371,182 275,882 190,968 41,379 18,498
Total Equity 371,182 275,882 190,968 41,379 18,498
Total Liabilities & Shareholder's Equity 412,312 311,694 220,537 68,753 51,902
Cash Flow 94,181 75,410 129,122 8,140 (6,408)
Working Capital 268,517 201,247 94,616 38,315 28,104
Free Cash Flow 135,029 115,367 60,516 18,197 3,113
Invested Capital 371,182 275,882 190,968 41,379 18,498
Shares Outstanding - Common Class Only 114,549 115,031 114,717 112,710 109,642
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 114,549 115,031 114,717 112,710 109,642
Total Common Shares Outstanding 114,549 115,031 114,717 112,710 109,642
Treasury Shares 5,218 1,807 - - -
Basic Weighted Shares Outstanding 114,349 115,343 113,527 110,566 106,883
Diluted Weighted Shares Outstanding 122,566 126,688 124,515 116,139 106,883